WSLHD
Skip navigation
Please use this identifier to cite or link to this item: https://wslhd.intersearch.com.au/wslhdjspui/handle/1/9563
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChen, J.-
dc.contributor.authorTu, Thomas-
dc.contributor.authorCohen, C.-
dc.contributor.authorWang, S.-
dc.contributor.authorHsu, Y. C.-
dc.contributor.authorGish, R. G.-
dc.date.accessioned2024-05-16T03:11:07Z-
dc.date.available2024-05-16T03:11:07Z-
dc.date.issued2024-
dc.identifier.citationHepatology 79(5):E132-E133, 2024-
dc.identifier.urihttps://wslhd.intersearch.com.au/wslhdjspui/handle/1/9563-
dc.subjectHepatitis B, Chronic-
dc.subjectLiver Cirrhosis-
dc.subjectAntiviral Agents-
dc.subjectHepatitis B virus-
dc.titleLetter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?-
dc.typeJournal Article-
dc.identifier.doihttps://dx.doi.org/10.1097/HEP.0000000000000732-
dc.identifier.journaltitleHepatology-
dc.identifier.departmentStorr Liver Centre-
dc.contributor.wslhdTu, Thomas-
dc.type.studyortrialLetter-
dc.identifier.pmid38150019-
dc.identifier.facilityWestmead-
Appears in Collections:Westmead Hospital 2019 - 2024

Files in This Item:
There are no files associated with this item.


Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.